Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CZR | VIPS |
|---|---|---|
| Price | $29.65 | $12.71 |
| Change today | ▲ 0.00% | ▲ 3.08% |
| Market cap | $6.04B | $6.04B |
| Return, 3 months | -2.3% | -6.1% |
| Return, year to date | +26.8% | -25.2% |
| Return, 1 year | +12.4% | -35.1% |
| P/E (TTM) | -13.1 | 4.1 |
| P/B | 1.8 | 0.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 4.92% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 49 | 48 |
| 30-day volatility | 1.7% | 26.5% |
| Max drawdown, 1 year | -34.9% | -39.1% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
